Scott Brydon is a seasoned professional in Market Access and Health Economics, currently serving as a Senior Health Economist at CSL, where they lead pharmacoeconomic submissions and engage with stakeholders to enhance patient access to medications. With a background as a pharmacist, they have accumulated extensive experience in oncology, nephrology, and rare diseases, developing successful reimbursement strategies at Bristol-Myers Squibb and CSL Vifor. Scott holds a Master of Business Administration from the University of Melbourne and a GradDip in Health Economics and Policy from Monash University, along with a Bachelor's degree in Pharmacy from the University of Otago. Their passion for delivering new treatments to Australian patients underscores their commitment to improving healthcare outcomes.
This person is not in the org chart
This person is not in any teams
This person is not in any offices